Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. more
Time Frame | PAVM | Sector | S&P500 |
---|---|---|---|
1-Week Return | -21.17% | -2.27% | -0.57% |
1-Month Return | -25.04% | -3.96% | 1.21% |
3-Month Return | -57.04% | -9.7% | 7.57% |
6-Month Return | -31.12% | -3.37% | 11.45% |
1-Year Return | -79.28% | 3.71% | 28.48% |
3-Year Return | -98.36% | 3.8% | 29.52% |
5-Year Return | -94.52% | 39.78% | 90.66% |
10-Year Return | -99.61% | 106.91% | 203.75% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | 500.00K | 377.00K | 2.45M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":20.39,"profit":true},{"date":"2022-12-31","value":15.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 14.23K | 23.00K | 585.00K | 3.61M | 6.42M | [{"date":"2019-12-31","value":0.22,"profit":true},{"date":"2020-12-31","value":0.36,"profit":true},{"date":"2021-12-31","value":9.11,"profit":true},{"date":"2022-12-31","value":56.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (14.23K) | (23.00K) | (85.00K) | (3.24M) | (3.97M) | [{"date":"2019-12-31","value":-1422600,"profit":false},{"date":"2020-12-31","value":-2300000,"profit":false},{"date":"2021-12-31","value":-8500000,"profit":false},{"date":"2022-12-31","value":-323700000,"profit":false},{"date":"2023-12-31","value":-396800000,"profit":false}] |
Gross Margin | (Infinity%) | (Infinity%) | (17.00%) | (858.62%) | (161.83%) | [{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":-17,"profit":false},{"date":"2022-12-31","value":-858.62,"profit":false},{"date":"2023-12-31","value":-161.83,"profit":false}] |
Operating Expenses | 14.30M | 23.35M | 54.31M | 87.69M | 64.83M | [{"date":"2019-12-31","value":16.3,"profit":true},{"date":"2020-12-31","value":26.63,"profit":true},{"date":"2021-12-31","value":61.93,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.93,"profit":true}] |
Operating Income | (14.30M) | (23.35M) | (54.39M) | (90.93M) | (68.80M) | [{"date":"2019-12-31","value":-1429529500,"profit":false},{"date":"2020-12-31","value":-2335100000,"profit":false},{"date":"2021-12-31","value":-5439300000,"profit":false},{"date":"2022-12-31","value":-9092700000,"profit":false},{"date":"2023-12-31","value":-6879500000,"profit":false}] |
Total Non-Operating Income/Expense | (3.56M) | (13.25M) | (2.26M) | (13.42M) | (10.92M) | [{"date":"2019-12-31","value":-355575700,"profit":false},{"date":"2020-12-31","value":-1325000000,"profit":false},{"date":"2021-12-31","value":-225600000,"profit":false},{"date":"2022-12-31","value":-1342300000,"profit":false},{"date":"2023-12-31","value":-1091600000,"profit":false}] |
Pre-Tax Income | (17.27M) | (35.89M) | (56.13M) | (103.24M) | (79.26M) | [{"date":"2019-12-31","value":-1726813100,"profit":false},{"date":"2020-12-31","value":-3588800000,"profit":false},{"date":"2021-12-31","value":-5612600000,"profit":false},{"date":"2022-12-31","value":-10323800000,"profit":false},{"date":"2023-12-31","value":-7926300000,"profit":false}] |
Income Taxes | (1.34M) | (1.56M) | (5.78M) | (1.94M) | (12.99B) | [{"date":"2019-12-31","value":-133682200,"profit":false},{"date":"2020-12-31","value":-155900000,"profit":false},{"date":"2021-12-31","value":-577900000,"profit":false},{"date":"2022-12-31","value":-194400000,"profit":false},{"date":"2023-12-31","value":-1299300000000,"profit":false}] |
Income After Taxes | (15.93M) | (34.33M) | (50.35M) | (101.29M) | 12.91B | [{"date":"2019-12-31","value":-0.12,"profit":false},{"date":"2020-12-31","value":-0.27,"profit":false},{"date":"2021-12-31","value":-0.39,"profit":false},{"date":"2022-12-31","value":-0.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | (17.27M) | (35.89M) | (56.13M) | (103.24M) | (86.43M) | [{"date":"2019-12-31","value":-1726813100,"profit":false},{"date":"2020-12-31","value":-3588800000,"profit":false},{"date":"2021-12-31","value":-5612600000,"profit":false},{"date":"2022-12-31","value":-10323800000,"profit":false},{"date":"2023-12-31","value":-8642700000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (15.93M) | (34.33M) | (50.35M) | (101.29M) | (64.17M) | [{"date":"2019-12-31","value":-1593130900,"profit":false},{"date":"2020-12-31","value":-3432900000,"profit":false},{"date":"2021-12-31","value":-5034700000,"profit":false},{"date":"2022-12-31","value":-10129400000,"profit":false},{"date":"2023-12-31","value":-6417500000,"profit":false}] |
EPS (Diluted) | (0.47) | (0.58) | (0.62) | (1.01) | (2.30) | [{"date":"2019-12-31","value":-47,"profit":false},{"date":"2020-12-31","value":-58,"profit":false},{"date":"2021-12-31","value":-62,"profit":false},{"date":"2022-12-31","value":-101,"profit":false},{"date":"2023-12-31","value":-230,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
PAVM | |
---|---|
Cash Ratio | 0.02 |
Current Ratio | 0.06 |
Quick Ratio | 0.06 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
PAVM | |
---|---|
ROA (LTM) | -80.07% |
ROE (LTM) | -1358.06% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
PAVM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.31 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.16 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
PAVM | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 2.27 |
P/B | 7.42 |
Price/FCF | NM |
EV/R | 11.41 |
EV/Ebitda | 3.90 |
PEG | NM |
PAVmed Inc (PAVM) share price today is $0.7646
Yes, Indians can buy shares of PAVmed Inc (PAVM) on Vested. To buy PAVmed Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PAVM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of PAVmed Inc (PAVM) via the Vested app. You can start investing in PAVmed Inc (PAVM) with a minimum investment of $1.
You can invest in shares of PAVmed Inc (PAVM) via Vested in three simple steps:
The 52-week high price of PAVmed Inc (PAVM) is $4.44. The 52-week low price of PAVmed Inc (PAVM) is $0.6.
The price-to-earnings (P/E) ratio of PAVmed Inc (PAVM) is
The price-to-book (P/B) ratio of PAVmed Inc (PAVM) is 7.42
The dividend yield of PAVmed Inc (PAVM) is 0.00%
The market capitalization of PAVmed Inc (PAVM) is $8.70M
The stock symbol (or ticker) of PAVmed Inc is PAVM